These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6095626)

  • 21. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
    Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
    J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC; Murphy WM; Daniel DS
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sodium saccharin and L-tryptophan on rat urine during bladder carcinogenesis.
    Demers DM; Fukushima S; Cohen SM
    Cancer Res; 1981 Jan; 41(1):108-12. PubMed ID: 7448750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
    Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW
    Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of promoters on incidence of bladder cancer in experimental animal models.
    Hicks RM
    Environ Health Perspect; 1983 Apr; 50():37-49. PubMed ID: 6873029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of Epstein-Barr virus antigens by tumor promoters for epidermal and nonepidermal tissues.
    Takada K; Zur Hausen H
    Int J Cancer; 1984 Apr; 33(4):491-6. PubMed ID: 6323326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: establishment of cell line, Nara Bladder Tumor II.
    Toyoshima K; Ito N; Hiasa Y; Kamamoto Y; Makiura S
    J Natl Cancer Inst; 1971 Nov; 47(5):979-85. PubMed ID: 4941696
    [No Abstract]   [Full Text] [Related]  

  • 31. The importance of synergy between weak carcinogens in the induction of bladder cancer in experimental animals and humans.
    Hicks RM; Chowaniec J
    Cancer Res; 1977 Aug; 37(8 Pt 2):2943-9. PubMed ID: 872124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
    Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
    Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter.
    Furukawa M; Sakashita H; Kamide M; Umeda R
    Auris Nasus Larynx; 1990; 17(1):49-54. PubMed ID: 2167654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agglutination assay of bladder cells by Concanavalin A proved the high susceptibility of analbuminemic rats to bladder carcinogens.
    Honma Y; Kakizoe T; Komatsu H; Niijima T; Sugimura T; Nagase S
    Cancer Lett; 1983 May; 19(1):7-11. PubMed ID: 6850570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of smokeless tobacco and tumor promoters on cell population growth and apoptosis of B lymphocytes infected with epstein-barr virus types 1 and 2.
    Jenson HB; Baillargeon J; Heard P; Moyer MP
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):171-82. PubMed ID: 10527916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine.
    Janzowski C; Jacob D; Henn I; Zankl H; Pool-Zobel BL; Wiessler M; Eisenbrand G
    IARC Sci Publ; 1991; (105):332-8. PubMed ID: 1855875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-stage carcinogenesis in the urinary bladder.
    Cohen SM
    Food Chem Toxicol; 1985; 23(4-5):521-8. PubMed ID: 4040099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on chemical carcinogen enhancement of Epstein-Barr virus induced transformation of human neonatal and adult peripheral blood lymphocytes.
    Henderson EE; Fronko G
    Int J Cancer; 1984 Mar; 33(3):331-8. PubMed ID: 6321362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multistage carcinogenesis in the urinary bladder.
    Cohen SM; Greenfield RE; Ellwein LB
    Environ Health Perspect; 1983 Mar; 49():209-15. PubMed ID: 6832093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.